Get the Stockscreener App
0.7879
2.61%
-0.0195
Lexicon Pharmaceuticals Inc Stock (LXRX) Forecast
The Lexicon Pharmaceuticals Inc (LXRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.0607, representing a +34.62% increase from the current price of $0.7879. The highest analyst price target is $0.9287, and the lowest is $1.1926.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LXRX Price Target
Average 1.2401
(+57.40% Upside)
Is Lexicon Pharmaceuticals Inc (LXRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 22.45 | Buy |
| STOCH(9,6) | 5.0328 | Buy |
| STOCHRSI(14) | 7.5766 | Buy |
| MACD(12,26) | -0.2297 | Sell |
| ADX(14) | 35.54 | Sell |
| William %R | -93.35 | Buy |
| CCI(14) | -134.96 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0251
Sell
|
1.0088
Sell
|
| MA20 |
1.2928
Sell
|
1.2069
Sell
|
| MA50 |
1.5415
Sell
|
1.4581
Sell
|
| MA100 |
1.6839
Sell
|
1.6025
Sell
|
| MA200 |
1.8658
Sell
|
1.6593
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, LXRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on LXRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 22.45 indicates that LXRX is oversold. This indicates that LXRX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 5.0328 indicates that LXRX is oversold. This indicates that LXRX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.5766 indicates that LXRX is oversold. This suggests that LXRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 35.54 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -134.96 indicates that LXRX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term LXRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lexicon Pharmaceuticals Inc financial reports and earnings history, Lexicon Pharmaceuticals Inc (LXRX) stock could reach $4.3157 by 2030, $3.7797 by 2040 and $12.46 by 2050. See the projected annual prices until 2050 of the Lexicon Pharmaceuticals Inc stock below:
- Lexicon Pharmaceuticals Inc (LXRX) is expected to reach an average price of $2.0913 in 2035, with a high prediction of $2.0657 and a low estimate of $2.0946. This indicates an $165.43% rise from the last recorded price of $0.7879.
- Lexicon Pharmaceuticals Inc (LXRX) stock is projected to chart a bullish course in 2040, with an average price target of $3.7723, representing an $378.78% surge from its current level. The forecast ranges from a conservative $3.7865 to a sky-high $3.7797.
- Our analysts predict Lexicon Pharmaceuticals Inc (LXRX) to jump 870.69% by 2045, soaring from $7.5546 to an average price of $7.6481, potentially reaching $7.4424. While $7.5546 is the low estimate, the potential upside is significant.
- Lexicon Pharmaceuticals Inc (LXRX) stock is expected to climb by 2050, reaching an average of $12.38, a $1,472% jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.46 and $12.62, respectively, highlighting the market's uncertainty.
Lexicon Pharmaceuticals Inc Stock (LXRX) Year by Year Forecast
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2024
Our forecast for LXRX stock price in 2024 now indicates an average price target of $1.9061 with a high forecast of $3.73 and a low forecast of $0.0822. The average prediction reflects an increase of +141.92% from the last recorded price of $0.7879.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.2054 | $1.1926 | $0.9287 | -73.93% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2025
Lexicon Pharmaceuticals Inc Stock (LXRX) is expected to reach an average price of $1.3074 in 2025, with a high prediction of $2.6083 and a low estimate of $0.00655. This indicates an +65.94% rise from the last recorded price of $0.7879.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.6294 | $0.00655 | $0.6934 | -20.12% |
| February, 2025 | $1.4372 | $0.6533 | $1.1122 | +82.41% |
| March, 2025 | $1.78 | $1.4592 | $1.48 | +125.92% |
| April, 2025 | $2.4498 | $2.187 | $2.3348 | +210.93% |
| May, 2025 | $2.4377 | $2.4957 | $2.4737 | +209.39% |
| June, 2025 | $2.4305 | $2.4605 | $2.3866 | +208.48% |
| July, 2025 | $2.2803 | $2.3974 | $2.2714 | +189.41% |
| August, 2025 | $2.2531 | $2.2585 | $2.2131 | +185.96% |
| September, 2025 | $2.3009 | $2.3109 | $2.1509 | +192.03% |
| October, 2025 | $2.4757 | $2.3279 | $2.3088 | +214.22% |
| November, 2025 | $2.5835 | $2.4996 | $2.4127 | +227.90% |
| December, 2025 | $2.8483 | $2.5644 | $2.6083 | +261.51% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2026
The predicted value for Lexicon Pharmaceuticals Inc (LXRX) in 2026 is set at an average of $2.9499. Estimates vary from a peak of $5.8873 to a trough of $0.0125, indicating an +274.40% surge from the present price of $0.7879.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.2862 | $2.4712 | $2.7903 | +190.16% |
| February, 2026 | $0.474 | $1.054 | $2.2731 | -39.84% |
| March, 2026 | $3.0682 | $0.0618 | $5.5982 | +289.41% |
| April, 2026 | $3.9834 | $3.2412 | $5.8873 | +405.57% |
| May, 2026 | $3.0056 | $2.2795 | $4.4164 | +281.46% |
| June, 2026 | $1.7377 | $1.6877 | $3.0786 | +120.55% |
| July, 2026 | $0.7629 | $0.5429 | $2.0269 | -3.17% |
| August, 2026 | $1.3551 | $0.519 | $1.5951 | +71.99% |
| September, 2026 | $0.6303 | $0.2303 | $2.5712 | -20.00% |
| October, 2026 | $0.1725 | $0.0125 | $0.6834 | -78.11% |
| November, 2026 | $1.3747 | $0.0614 | $1.6747 | +74.47% |
| December, 2026 | $1.5399 | $1.0938 | $2.1299 | +95.44% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lexicon Pharmaceuticals Inc (LXRX) is $1.5591, with a high forecast of $3.0889 and a low forecast of $0.0293. This indicates an +97.88% increase from the last price of $0.7879.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.8621 | $1.4079 | $3.0889 | +136.33% |
| February, 2027 | $1.7842 | $1.5281 | $2.5871 | +126.45% |
| March, 2027 | $0.7594 | $0.6094 | $2.0573 | -3.61% |
| April, 2027 | $0.3916 | $0.2116 | $1.6345 | -50.30% |
| May, 2027 | $0.0338 | $0.0293 | $0.4446 | -95.71% |
| June, 2027 | $0.811 | $0.0332 | $0.621 | +2.93% |
| July, 2027 | $0.7988 | $0.8119 | $0.748 | +1.39% |
| August, 2027 | $0.8367 | $0.5697 | $0.6258 | +6.19% |
| September, 2027 | $1.0315 | $1.0286 | $0.9845 | +30.91% |
| October, 2027 | $1.2593 | $1.0284 | $1.1793 | +59.83% |
| November, 2027 | $0.2029 | $0.7906 | $0.6302 | -74.25% |
| December, 2027 | $0.5681 | $0.0741 | $0.6681 | -27.90% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2028
In 2028, Lexicon Pharmaceuticals Inc (LXRX) is projected to reach an average price of $0.8763, with a high projection of $1.7479 and a low estimate of $0.00459. This indicates an +11.21% rise from the last price of $0.7879.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1703 | $0.0822 | $0.8911 | -78.39% |
| February, 2028 | $0.0976 | $0.0133 | $0.4233 | -87.62% |
| March, 2028 | $0.2823 | $0.2145 | $0.2454 | -64.16% |
| April, 2028 | $0.2502 | $0.2132 | $0.1502 | -68.25% |
| May, 2028 | $0.365 | $0.2541 | $0.235 | -53.68% |
| June, 2028 | $0.0572 | $0.0628 | $0.3119 | -92.74% |
| July, 2028 | $0.0694 | $0.0237 | $0.2713 | -91.19% |
| August, 2028 | $0.0646 | $0.00459 | $0.7546 | -91.80% |
| September, 2028 | $0.2768 | $0.0407 | $0.4068 | -64.87% |
| October, 2028 | $1.4489 | $0.2375 | $1.7479 | +83.90% |
| November, 2028 | $0.7691 | $0.5741 | $1.542 | -2.38% |
| December, 2028 | $0.3663 | $0.1563 | $1.1522 | -53.51% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2029
The 2029 price forecast for Lexicon Pharmaceuticals Inc Stock (LXRX) is $1.4542 on average, with a high prediction of $2.89 and a low estimate of $0.0185. This represents an +84.57% increase from the previous price of $0.7879.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1515 | $0.0185 | $0.4824 | -80.77% |
| February, 2029 | $0.0237 | $0.1104 | $0.1546 | -96.99% |
| March, 2029 | $0.3541 | $0.0733 | $0.1391 | -55.05% |
| April, 2029 | $0.512 | $0.6761 | $0.6158 | -35.02% |
| May, 2029 | $0.6267 | $0.4448 | $0.4659 | -20.45% |
| June, 2029 | $0.4346 | $0.5307 | $0.4376 | -44.84% |
| July, 2029 | $0.00241 | $0.2124 | $0.2415 | -99.69% |
| August, 2029 | $0.4028 | $0.0794 | $0.5028 | -48.88% |
| September, 2029 | $1.125 | $0.3958 | $2.3019 | +42.78% |
| October, 2029 | $0.9102 | $0.7141 | $1.4662 | +15.52% |
| November, 2029 | $0.3524 | $0.3024 | $1.1332 | -55.28% |
| December, 2029 | $3.43 | $0.2084 | $2.89 | +335.33% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2030
Lexicon Pharmaceuticals Inc Stock (LXRX) is expected to reach an average price of $6.1061 in 2030, with a high forecast of $8.4309 and a low forecast of $3.7813. This signifies an +674.98% surge from the last price of $0.7879.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.3896 | $4.0439 | $4.3157 | +457.12% |
| February, 2030 | $3.7152 | $3.7813 | $3.7274 | +371.54% |
| March, 2030 | $8.6259 | $4.6891 | $8.4309 | +994.80% |
| April, 2030 | $8.3966 | $8.4426 | $8.3666 | +965.69% |
| May, 2030 | $6.5896 | $6.7422 | $8.2505 | +736.35% |
| June, 2030 | $5.6018 | $6.314 | $6.1179 | +610.98% |
| July, 2030 | $5.5014 | $5.7296 | $5.6174 | +598.23% |
| August, 2030 | $4.752 | $4.6431 | $5.3553 | +503.12% |
| September, 2030 | $5.1277 | $5.1448 | $4.9427 | +550.80% |
| October, 2030 | $6.1022 | $5.2116 | $5.7322 | +674.50% |
| November, 2030 | $6.9279 | $6.3262 | $6.5979 | +779.29% |
| December, 2030 | $7.0424 | $7.0057 | $6.8436 | +793.81% |
1.80%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):